|
KMID : 0338420020170020094
|
|
The Korean Journal of Internal Medicine
2002 Volume.17 No. 2 p.94 ~ p.99
|
|
|
The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii
|
|
Hyun Joo Pai/Na Young Kwon
Jae Deok Kim/Hyun Joo Pai
|
|
|
Abstract
|
|
|
Background: Despite increasing importance of Acinetobacter baumannii in nosocomial infections and rapid development of multi-antimicrobial resistance in this strain, the resistance mechanisms of β-lactam antimicrobials in A. baumannii were not clearly defined. In order to observe the resistance mechanisms against β-lactams and carbapenem, we characterized the production of β-lactamases and outermembrane protein (OMP) profiles for the 44 clinical isolates of A. baumannii.
Methods: The MICs of antimicrobials were determined by agar dilution test. The secondary β-lactamases were characterized by isoelectric focusing, polymerase chain reactions and nucleotide sequencing, and the production of chromosomal β-lactamases was quantitated by spectrophotometric method. For two strains with an elevated MIC of carbapenem, outermembrane protein (OMP) profile was analyzed by ultracentrifugation of the sonicated bacteral cells and SDS-PAGE.
Results and conclusion: Twenty two or 4 of 44 strains produced TEM-1-like β-lactamase or PER-1 extended-spectrum β-lactamase, respectively. However, when we analyzed the MICs of several β-lactams with the β-lactamase production, the resistance level of β-lactam was mainly determined by the production of chromosomal β-lactamase, not by the secondary β-lactamases in the clinical isolates of A. baumannii. In two strains with an elevated MIC of imipenem, a decrease or loss of about 35 kDa and 22 kDa proteins in OMP was observed, which suggested that the change of OMP played a role in carbapenem resistance.
|
|
|
KEYWORD
|
|
|
Acinetobacter baumanni, β-lactams, carbapenem, β-lactamase, OMP,
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|
|